AMC Media Group has been acquired by Formedics
August 2024 — AMC Media Group, a healthcare professional (HCP) community platform that enables medical associations and key opinion leaders (KOLs) to drive engagement and monetization through their specialty digital properties, has been acquired by Formedics, an HCP community and engagement platform that is home to Physician’s Weekly and OncWeekly.
AMC Media Group offers business development, digital advertising and healthcare publishing services to medical experts across the US. Its mission is to activate peer connections that facilitate HCP learning while helping brands access key audiences.
Formedics is an HCP community and engagement platform that supports and connects healthcare professionals wherever they practice medicine or choose to learn. In addition to its leading HCP network, Formedics’ groundbreaking AI/ML technology unlocks unrivaled healthcare targeting and engagement for pharmaceutical and life science brands. The Formedics properties include Physician’s Weekly, Figure 1, OncWeekly and AMC Media Group.
Our role in the transaction
Oaklins DeSilva+Phillips, one of Oaklins’ TMT teams in New York, served as the exclusive financial advisor to AMC Media Group on the transaction. This transaction emphasizes ODP’s deep sector expertise in advising digital media businesses, specifically those within the healthcare communications and technology industry.
JC Landry
President, AMC Media Group
Kontakt ansvarlige rådgivere
Jon Guttenberg
Oaklins DeSilva+Phillips
Relaterte transaksjoner
Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Les merNextalia has acquired a majority stake in Witapp
Nextalia SGR S.p.A. has acquired a majority stake in Witapp S.r.l., an Italian company specializing in software development for the digitization of healthcare infrastructure. The acquisition strengthens Nextalia’s track record in technology companies serving the public sector and supports its strategy of investing in businesses operating at the intersection of healthcare digitization and the modernization of public services.
Les merLife & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Les mer